We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current BBIO market cap is 4.82B. The company's latest EPS is USD -3.4372 and P/E is -7.49.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.83M | 1.64M | 4.09M | 1.75M | 211.12M |
| Operating Income | -126.16M | -146.1M | -157.69M | -177.42M | 343k |
| Net Income | -140.16M | -157.9M | -177M | -168.15M | -35.22M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 40.56M | 8.25M | 69.72M | 77.65M | 9.3M |
| Operating Income | -287.11M | -474.48M | -546.72M | -512.2M | -607.37M |
| Net Income | -260.59M | -448.72M | -562.54M | -481.18M | -643.2M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 625.68M | 503.66M | 655.01M | 546.38M | 849.33M |
| Total Liabilities | 1.84B | 1.85B | 1.85B | 1.89B | 1.89B |
| Total Equity | -1.21B | -1.35B | -1.2B | -1.34B | -1.04B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 631.68M | 703.59M | 1.01B | 623.04M | 546.38M |
| Total Liabilities | 155.7M | 595.7M | 1.88B | 1.87B | 1.89B |
| Total Equity | 473.73M | 106.26M | -867M | -1.24B | -1.34B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -144.32M | -257.68M | -402.9M | -527.72M | -219.54M |
| Investing | 12.3M | 16.42M | 54.1M | 54.03M | 22.75M |
| Financing | 150.25M | 149.02M | 456.06M | 451.54M | 279.55M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -253.59M | -399.71M | -497.93M | -419.49M | -527.72M |
| Investing | -217.25M | -52.99M | -200.83M | 453.15M | 54.03M |
| Financing | 398.79M | 447.19M | 736.45M | -13.13M | 451.54M |
| Market Cap | 4.82B |
| Price to Earnings Ratio | -7.49 |
| Price to Sales Ratio | 517.91 |
| Price to Cash Ratio | 12.81 |
| Price to Book Ratio | -3.59 |
| Dividend Yield | - |
| Shares Outstanding | 187.13M |
| Average Volume (1 week) | 2.98M |
| Average Volume (1 Month) | 2.87M |
| 52 Week Change | 52.43% |
| 52 Week High | 44.32 |
| 52 Week Low | 16.61 |
| Spread (Intraday) | 0.67 (2.58%) |
| Company Name | BridgeBio Pharma Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.bridgebio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
